# Neocartilage Implant to Treat Cartilage Lesions of the Knee

> **NCT01400607** · PHASE3 · TERMINATED · sponsor: **ISTO Technologies, Inc.** · enrollment: 14 (actual)

## Conditions studied

- Articular Cartilage Disorder
- Degeneration; Articular Cartilage
- Chronic Cartilage Injury
- Acute Cartilage Injury
- Defect of Articular Cartilage

## Interventions

- **BIOLOGICAL:** Neocartilage Implant/DeNovo® ET (Engineered Tissue Graft)
- **OTHER:** Microfracture

## Key facts

- **NCT ID:** NCT01400607
- **Lead sponsor:** ISTO Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2017-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400607, "Neocartilage Implant to Treat Cartilage Lesions of the Knee". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01400607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*